Clinical Trial Update: Early Phase Study of KESONOTIDE™in Participants With Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

KESONOTIDE is being studied in an early-phase (Phase 1/Phase 2) trial for solid tumours and is currently recruiting across multiple cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Glioblastoma
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Skin Cancer

Drugs mentioned

• KESONOTIDE

Snippet

Sponsor: Filamon LTD | Conditions: Prostate Cancers, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING